BRIEF-Vermillion jumps after medical journal study on ovarian cancer test

NEW YORK Wed Nov 28, 2012 11:00am EST

NEW YORK Nov 28 (Reuters) - Vermillion Inc : * Jumps 45.4 percent to $1.73 after medical journal Gynecologic Oncology published clinical study results of the company's ovarian cancer test

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.